A detailed history of Davidson Investment Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Davidson Investment Advisors holds 2,870 shares of ABBV stock, worth $514,303. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,870
Previous 2,870 -0.0%
Holding current value
$514,303
Previous $492,000 15.04%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $35,959 - $40,972
-225 Reduced 7.27%
2,870 $522,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $98,624 - $113,580
-682 Reduced 18.06%
3,095 $493,000
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $59,888 - $71,821
-433 Reduced 10.29%
3,777 $610,000
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 2.32%
4,210 $565,000
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $19,954 - $25,369
-145 Reduced 3.25%
4,310 $660,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $7,918 - $9,825
60 Added 1.37%
4,455 $722,000
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $135,361 - $171,271
-1,260 Reduced 22.28%
4,395 $595,000
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $206,096 - $233,950
-1,937 Reduced 25.51%
5,655 $610,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $2,630 - $2,930
25 Added 0.33%
7,592 $855,000
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $556,716 - $612,878
-5,442 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $438,026 - $591,382
5,442 New
5,442 $583,000
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $3,225 - $4,889
-50 Reduced 0.89%
5,555 $423,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $5,409 - $6,768
-75 Reduced 1.32%
5,605 $496,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $8,628 - $10,373
-137 Reduced 2.36%
5,680 $430,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $9,855 - $12,597
-150 Reduced 2.51%
5,817 $423,000
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $515,835 - $607,112
-6,687 Closed
0 $0
Q4 2018

Jan 29, 2019

SELL
$77.85 - $96.01 $18,450 - $22,754
-237 Reduced 3.42%
6,687 $616,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $30,229 - $33,605
-340 Reduced 4.68%
6,924 $655,000
Q2 2018

Aug 02, 2018

BUY
$89.78 - $106.23 $28,639 - $33,887
319 Added 4.59%
7,264 $673,000
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $343,013 - $459,326
-3,728 Reduced 34.93%
6,945 $657,000
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $74,872 - $82,103
836 Added 8.5%
10,673 $1.03 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $6,426 - $8,208
92 Added 0.94%
9,837 $874,000
Q2 2017

Aug 11, 2017

BUY
N/A
9,745
9,745 $706,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Davidson Investment Advisors Portfolio

Follow Davidson Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.